» Articles » PMID: 7755693

Mortality in Relation to Smoking: 40 Years' Observations on Male British Doctors

Overview
Journal BMJ
Specialty General Medicine
Date 1994 Oct 8
PMID 7755693
Citations 445
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the hazards associated with long term use of tobacco.

Design: Prospective study of mortality in relation to smoking habits assessed in 1951 and again from time to time thereafter, with causes sought of deaths over 40 years (to 1991). Continuation of a study that was last reported after 20 years' follow up (1951-71).

Subjects: 34,439 British male doctors who replied to a postal questionnaire in 1951, of whom 10,000 had died during the first 20 years and another 10,000 have died during the second 20 years.

Results: Excess mortality associated with smoking was about twice as extreme during the second half of the study as it had been during the first half. The death rate ratios during 1971-91 (comparing continuing cigarette smokers with life-long non-smokers) were approximately threefold at ages 45-64 and twofold at ages 65-84. The excess mortality was chiefly from diseases that can be caused by smoking. Positive associations with smoking were confirmed for death from cancers of the mouth, oesophagus, pharynx, larynx, lung, pancreas, and bladder; from chronic obstructive pulmonary disease and other respiratory diseases; from vascular diseases; from peptic ulcer; and (perhaps because of confounding by personality and alcohol use) from cirrhosis, suicide, and poisoning. A negative association was confirmed with death from Parkinson's disease. Those who stopped smoking before middle age subsequently avoided almost all of the excess risk that they would otherwise have suffered, but even those who stopped smoking in middle age were subsequently at substantially less risk than those who continued to smoke.

Conclusion: Results from the first 20 years of this study, and of other studies at that time, substantially underestimated the hazards of long term use of tobacco. It now seems that about half of all regular cigarette smokers will eventually be killed by their habit.

Citing Articles

Genetically predicted 486 blood metabolites in relation to risk of esophageal cancer: a Mendelian randomization study.

Jia C, Yi D, Ma M, Xu Q, Ou Y, Kong F Front Mol Biosci. 2024; 11:1391419.

PMID: 39417005 PMC: 11479936. DOI: 10.3389/fmolb.2024.1391419.


The hidden impact: the rate of nicotine metabolism and kidney health.

Wang X, Su S Front Endocrinol (Lausanne). 2024; 15:1424068.

PMID: 39355620 PMC: 11442274. DOI: 10.3389/fendo.2024.1424068.


SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats.

Braunscheidel K, Voren G, Fowler C, Lu Q, Kuryatov A, Cameron M Front Mol Neurosci. 2024; 17:1459098.

PMID: 39346680 PMC: 11428108. DOI: 10.3389/fnmol.2024.1459098.


Exploring the Determinants of Tobacco Usage Among Adolescents: A Cross-Sectional Study in Western Maharashtra.

Gangurde S, Shivale S, Rathod H, Verma P, Madamanchi D, Mahajan A Cureus. 2024; 16(8):e66755.

PMID: 39268314 PMC: 11392507. DOI: 10.7759/cureus.66755.


Branched-chain amino acids and risk of lung cancer: insights from mendelian randomization and NHANES III.

Li Z, Hao J, Wang T, Guo C, Liu L J Thorac Dis. 2024; 16(8):5248-5261.

PMID: 39268127 PMC: 11388241. DOI: 10.21037/jtd-24-420.


References
1.
Marmot M, Brunner E . Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ. 1991; 303(6802):565-8. PMC: 1670912. DOI: 10.1136/bmj.303.6802.565. View

2.
Longnecker M, Orza M, Adams M, Vioque J, CHALMERS T . A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control. 1990; 1(1):59-68. DOI: 10.1007/BF00053184. View

3.
DOLL R, Gray R, Hafner B, Peto R . Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J. 1980; 280(6219):967-71. PMC: 1601142. DOI: 10.1136/bmj.280.6219.967. View

4.
Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K . Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed). 1988; 296(6618):313-6. PMC: 2544821. DOI: 10.1136/bmj.296.6618.313. View

5.
Peto R, Lopez A, Boreham J, Thun M, Heath Jr C . Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992; 339(8804):1268-78. DOI: 10.1016/0140-6736(92)91600-d. View